{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T10:00:12Z","timestamp":1778320812510,"version":"3.51.4"},"reference-count":2,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1001\/jamadermatol.2018.4070","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T22:34:52Z","timestamp":1543271692000},"page":"122","source":"Crossref","is-referenced-by-count":16,"title":["Metastatic Calcinosis Cutis Associated With a Selective FGFR Inhibitor"],"prefix":"10.1001","volume":"155","author":[{"given":"David R.","family":"Carr","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Medicine, The Ohio State University, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Llana","family":"Pootrakul","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, The Ohio State University, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Zi","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, The Ohio State University, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine G.","family":"Chung","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, The Ohio State University, Columbus"},{"name":"Division of Dermatopathology, Department of Pathology, The Ohio State University, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"2","key":"dlo180028r1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/toxsci\/kft161","article-title":"Pan-FGFR inhibition leads to blockade of FGF23 signaling, soft tissue mineralization, and cardiovascular dysfunction.","volume":"135","author":"Yanochko","year":"2013","journal-title":"Toxicol Sci"},{"issue":"3","key":"dlo180028r2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1200\/JCO.2017.75.5009","article-title":"Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma.","volume":"36","author":"Javle","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2715091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T20:30:11Z","timestamp":1547065811000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.4070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,1]]},"references-count":2,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.4070","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,1]]}}}